Welcome to the international HTA database

Showing [21043 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Costs and effects of two modes for disease management of chronic obstructive pulmonary disease (COPD) in general practice. A randomized controlled trial comparing regular nurse practitioner review and self-management education]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Costs and effects of strategies to prevent oversedation in intensive care patients]
2013	National Evidence-based Healthcare Collaborating Agency (NECA)	[Costing methods in healthcare]
2010	Belgian Health Care Knowledge Centre (KCE)	[Cost-utility of vaccination against chickenpox in children and against herpes zoster in elderly in Belgium]
2011	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Cost-utility analysis of the introduction of universal infant rotavirus vaccination in Spain]
2010	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Cost-utility analysis of pharmacological treatments for the prevention of bone fractures in osteoporotic post-menopausal Spanish women]
2020	Canary Health Service	[Cost-effectiveness of universal childhood vaccination against hepatitis A (update)]
2012	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of two strategies to implement the NVOG guidelines on hypertension in pregnancy: an innovative strategy including a computerised decision support system compared to a common strategy of professional audit & feedback]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of two different strategies to implement the NVOG guideline programme on subfertility]
2012	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of the demands and capacities model based treatment compared to the Lidcombe programme of early stuttering intervention: randomised trial]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of the Australian medical sheepskin for the prevention of pressure ulcers in somatic nursing home clients]
2006	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of selecting compatible donor blood in Rhc- and RhE negative females during and before reproductive age to prevent hemolytic disease in the newborn (HDN)]
2014	Basque Office for Health Technology Assessment (OSTEBA)	[Cost-effectiveness of percutaneous aortic valve replacement using prosthetic valve versus the standard surgical treatment]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of nutritional screening and intervention in elderly subjects after hip fracture]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of monitoring of psychotherapeutic treatments: a randomized comparison on the effects of feedback to therapists and patients in three settings of outpatient psychotherapy]
2013	National Evidence-based Healthcare Collaborating Agency (NECA)	[Cost-effectiveness of human papillomavirus vaccination in South Korea]
2008	Center for Medical Technology Assessment (CMT)	[Cost-effectiveness of hearing aids - linear vs non-linear characteristics]
2006	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of follow-up of patients with superficial bladder cancer]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of different strategies for the treatment and monitoring of ocular hypertension and glaucoma]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of decision rules for the use of CT for minimal head injury]
2014	National Evidence-based Healthcare Collaborating Agency (NECA)	[Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in South Korea]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of cognitive behaviour therapy for recent onset schizophrenia patients with persistent and recurrent psychosis]
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	[Cost-effectiveness of childhood vaccination against rotavirus in Norway]
2010	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of care for patients with type 2 diabetes, an evaluation of an innovative shared diabetes care model ("Ketenzorg model")]
2007	Center for Medical Technology Assessment (CMT)	[Cost-effectiveness of assistive technologies - walkers]
2001	Basque Office for Health Technology Assessment (OSTEBA)	[Cost-effectiveness analysis of treatments of sleep apnea syndrome in the Basque Country]
2008	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Cost-effectiveness analysis of population screening tests for colorectal cancer: systematic review of the efficacy and safety]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Cost-effectiveness analysis of a telemonitoring experiment in patients with cardiac insufficiency and chronic obstructive pulmonary disease]
2010	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Cost-benefits evaluation of prevention and control of nosocomial MRSA infections]
2011	Health Intervention and Technology Assessment Program (HITAP)	[Cost-benefit analysis of prenatal screening and diagnosis for Down syndrome in Thailand]
2015	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Cost studies of type 2 diabetes: a review of literature]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Cost evaluation of the early breast cancer detection programme of the Autonomous Community of the Basque Country]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost effectiveness of two different implementation procedures to change clinicians practice roles in the detection of hereditary colorectal cancer]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost effectiveness of scalp cooling in the prevention of chemotherapy-induced hair loss]
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Cost effectiveness of different types of coronary stents which are used in patients with acute coronary syndrome (ACS)]
2022	Gesundheit Osterreich GmbH (GOeG)	[Cost effectiveness of communication training for health care professionals]
2011	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost effectiveness of a collaborative stepped care intervention for anxiety disorders in the primary care setting]
2015	Basque Office for Health Technology Assessment (OSTEBA)	[Cost effective analysis of negative pressure wound therapy for the treatment of venous ulcers in legs]
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Cost and budget impact analysis of an increase in day surgery for selected indications]
2008	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis]
2007	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis]
2013	Basque Office for Health Technology Assessment (OSTEBA)	[CORREX® aortic valve bypass for treatment of severe aortic stenosis]
2021	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Coronary lithoplasty for coronary heart disease - Assessment according to §137h Social Code Book V]
2021	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Coronary lithoplasty for coronary heart disease - Addendum to commission H20-07]
2022	Institute for Clinical Effectiveness and Health Policy (IECS)	[Coronary intravascular lithotripsy in coronary artery disease]
2001	Finnish Office for Health Care Technology Assessment (Finohta)	[Coronary angioplasty in Finland: an overview of the situation in 2000 and an estimation of needs in the near future]
2009	Committee for New Health Technology Assessment (CNHTA)	[Corneal cross linking]
2022	Institute for Clinical Effectiveness and Health Policy (IECS)	[Corneal collagen crosslinking with riboflavin in keratoconus]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Corneal collagen crosslinking with riboflavin for keratoconus patients]
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Corneal collagen crosslinking for keratoconus patients]
2015	Haute Autorite de sante (HAS)	[Corneal collagen cross-linking and intrastromal corneal ring segments in the treatment of corneal ectasia]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Corifollitropin alfa (Elonva®) for controlled ovarian stimulation in assisted human reproductive techniques]
2021	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Coping strategies in complex medical situations - the example of coronary heart disease]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Conventional Or Magnetic resonance angiography after Endovascular Treatment of intracranial aneurysms (COMET)]
2019	Basque Office for Health Technology Assessment (OSTEBA)	[Controlled and uncontrolled donation after circulatory death with regional normothermic or hypothermic perfusion based on extracorporeal membrane oxygenation for kidney and liver transplants]
2011	Finnish Office for Health Care Technology Assessment (Finohta)	[Continuous wound infusion of local anaesthetic agents for postoperative analgesia]
2012	Finnish Office for Health Care Technology Assessment (Finohta)	[Continuous subcutaneous insulin infusion in type 1 diabetes mellitus]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Continuous subcutaneous infusion pump for diabetic patients]
2013	The Swedish Council on Health Technology Assessment (SBU)	[Continuous subcutaneous glucose monitoring for diabetes]
2010	Committee for New Health Technology Assessment (CNHTA)	[Continuous local delivery of anesthesia to operative sites using an elastomeric infusion pump]
2015	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Continuous interstitial glucose monitoring (CGM) with real-time measurement devices in insulin-dependent diabetes mellitus]
2010	The Netherlands Organisation for Health Research and Development (ZonMw)	[Continuous flow registration for early detection of hepatic artery thrombosis after liver transplantation. Innovative technology reducing retransplantation rate?]
2009	Committee for New Health Technology Assessment (CNHTA)	[Continuous femoral nerve block]
2005	Andalusian Health Technology Assessment Area (AETSA)	[Continuous blood glucose monitoring system "GlucoWatch"]
2008	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Continuous anaesthetic infusion system at the surgical site]
2021	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Continuity of care]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Contaminants from the treatment of drinking water in the Autonomous Community of the Basque Country: Assessment of the risk and alternative treatments]
2011	Agenzia nazionale per i servizi sanitari regionali (Agenas)	[Consultation on the spread of tele-assistance for the management of the patient in post-stroke rehabilitation]
2008	Center for Medical Technology Assessment (CMT)	[Consequences appearing to family carers]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Consensus recommendations on post-traumatic brain injury (TBI) rehabilitation]
2021	Health Sciences Institute in Aragon (IACS)	[Congenital ventricular septal defect (VSD) treatment with percutaneous and periventricular insertion devices]
2008	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Congenital hypothyroidism: clinical practice guideline]
2010	Andalusian Health Technology Assessment Area (AETSA)	[Confocal microscopy in ophthalmology: Report summary of emergent technology]
2009	Basque Office for Health Technology Assessment (OSTEBA)	[Confidentiality of medical records. Analysis of the current situation and areas for improvement in their use and management]
2022	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Conductive intravesical chemohyperthermia with mitomycin in non-muscle invasive bladder cancer: review of guidelines and ongoing research]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Conditions for regional implementation of a national careprogramme anxiety disorders, based on the multidisciplinary evidence based guideline on anxiety disorders]
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Concepts of care for people with dementia]
2022	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Concept for routine practice data collection for valoctocogene roxaparvovec acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2022	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Concept for routine practice data collection for risdiplam acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2022	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Concept for routine practice data collection for fedratinib acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2023	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Concept for routine practice data collection for etranacogene dezaparvovec acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2023	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Concept for routine practice data collection for brexucabtagene autoleucel acc. to the Law for More Safety in the Supply of Medicines (GSAV)]
2022	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Concept for routine practice data collection - autologous anti-CD19-transduced CD3+ cells]
2018	Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Concept for a national health portal]
2009	The Swedish Council on Health Technology Assessment (SBU)	[Computerized training for children with ADHD]
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Computerized physician order entry - effectiveness and efficiency of electronic medication ordering with decision support systems]
2000	Basque Office for Health Technology Assessment (OSTEBA)	[Computerised axial tomography: equipments and use in the ACBC. Instructions on the appropriate use of CAT]
2008	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Computer-based cognitive behavioral therapy]
2007	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Computer-assisted surgery in knee surgery - a health technology assessment]
2010	The Netherlands Organisation for Health Research and Development (ZonMw)	[Computer-assisted minimally invasive total hip surgery (MIS): a randomised controlled trial into the effectiveness compared to traditional total hip arthroplasty (THA)]
2011	The Swedish Council on Health Technology Assessment (SBU)	[Computer-Aided Detection (CAD) in mammography screening]
2011	Institut national d'excellence en sante et en services sociaux (INESSS)	[Computed tomography and its carcinogenic effects in children and youth in Québec]
2012	Institut national d'excellence en sante et en services sociaux (INESSS)	[Complications associated with the surgical instruments used in tonsillectomies]
2015	Institut national d'excellence en sante et en services sociaux (INESSS)	[Complex wound treatment: negative pressure therapy]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Complete exome sequencing in epileptic encephalopathy]
2010	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Comparison of tools for assessing the methodological quality of primary and secondary studies in health technology assessment reports in Germany]
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Comparison of the effectiveness of slow-release dosage forms (depot) versus oral dosage forms of antipsychotics (typical and atypical), marketed in Catalonia, in patients with a diagnosis of schizophrenia]
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Comparative results of the different screening strategies used for T21, T18 and T13: adaptation of the EUnetHTA assessment]
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Comparative effectiveness study of catheter ablation for atrial fibrillation]
2013	National Evidence-based Healthcare Collaborating Agency (NECA)	[Comparative effectiveness research of computer-assisted navigation in knee arthroplasty]